ERS GenomicsJun28New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurgeby ERS Genomics | June 28, 2022580Dublin, Ireland | ERS Genomics Limited [1] (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG [2] (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge ac... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 28, 2022
Stony Brook University (SUNY)Jun22Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processesby Stony Brook University (SUNY) | June 22, 2022532Stony Brook, NY | Gábor Balázsi [1] , PhD, and his research team in the Laufer Center [2] and the Department of Biomedical Engineering [3] at Stony Brook University are embarking upon a new way to res... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 22, 2022
Claudia FreyMar30Cytosurge launches cell line engineering services based on proprietary FluidFM® technologyby Claudia Frey | March 30, 2022852Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 30, 2022
Claudia FreyJan18R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisseby Claudia Frey | January 18, 2022808Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) [2] at the ... Read more > Press ReleaseCorporateFluidFM ApplicationsJan 18, 2022
Claudia FreyMar24Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeksby Claudia Frey | March 24, 20211210Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation [2] , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 24, 2021
Claudia FreyMay04Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editingby Claudia Frey | May 4, 20201859Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University [1] and Cytosurge AG [2] , a company manufacturing unique high-precision ... Read more > Press ReleaseCorporateFluidFM ApplicationsMay 4, 2020
Claudia FreyJul14FluidFM single cell extractionby Claudia Frey | July 14, 2016818Zurich | A groundbreaking new method for single cell analysis based on FluidFM® technology allows scientist to investigate the behavior of individual cells within their natural environment. The new me... Read more > Press ReleaseCorporateFluidFM ApplicationsJul 14, 2016
